Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II

The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment

(2010) Kelly K. Haagenson et al.   CANCER AND METASTASIS REVIEWS

Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance

(2010) Wisinee Chanmahasathien et al.   PHYTOMEDICINE

Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription

(2009) Huiling Shen et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture

(2009) Wing-Sai Chan et al.   NEUROCHEMISTRY INTERNATIONAL

Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism

(2008) Jiangeng Huang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and Cancer

(2008) T. Boutros et al.   PHARMACOLOGICAL REVIEWS

Inhibition of MDR1 expression by retinol treatment increases sensitivity to etoposide (VP16) in human neoplasic cell line

(2008) Fábio Klamt et al.   TOXICOLOGY IN VITRO

Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells

(2008) Xia Li et al.   TOXICOLOGY IN VITRO